Be proactive with non-invasive biomarkers — monitor Reactive Oxygen Species (ROS) to detect early signs of oxidative stress before clinical symptoms appear.
These are the essential questions—
At Alpha Science, we provide the evidence-based answers.
A root driver of inflammation, immune imbalance, delayed recovery, and reduced stamina—long before clinical signs emerge.
Reactive Oxygen Species (ROS) are unstable molecules generated during normal metabolism and physical exertion. When left unbalanced, they drive oxidative stress—a systemic process that damages cells, disrupts performance, and accelerates aging.
Today’s equine veterinary science recognizes oxidative stress as a central contributor to multiple physiologic breakdowns:
ROS impair neuronal and muscular energy regulation, leading to subtle changes in behavior, focus, and responsiveness—especially in aging and competition horses.
Oxidative damage precedes visible cardiovascular pathology, contributing to decreased circulatory efficiency and early remodeling under intense training.
Excess oxidative load interferes with insulin signaling and nutrient utilization, elevating inflammation and fatigue in overweight, insulin-resistant, or metabolically sensitive horses.
Mitochondrial stress reduces stamina, increases post-exercise soreness, and slows recovery—compromising conditioning programs and competitive edge.
Oxidative imbalance suppresses immune resilience and drives persistent low-grade inflammation, which may predispose to infections and slower healing.
Persistent ROS exposure damages DNA, impairs tissue repair, and accelerates musculoskeletal wear and tear.
We believe veterinary care should be proactive—not reactive.
Our platform enables equine professionals to detect and manage oxidative stress before it becomes clinical disease.
All of our tests are non-invasive, field-ready, and actionable, ideal for use in:
Our biomarker suite includes:
uMDA-Vet™
A non-invasive, urine-based marker for malondialdehyde (MDA), reflecting real-time oxidative damage to cellular lipids.
Hcy-Vet™ (POC handheld device) *coming soon
An in-clinic plasma test for homocysteine, offering immediate insight into methylation efficiency and systemic redox stress at the point of care.
uCU/ZN-Vet™
A urinary copper-to-zinc ratio that reflects trace mineral balance and antioxidant enzyme cofactor activity.
With Alpha Science, you're not just measuring a number—you’re gaining a clinical advantage.
We don’t wait for lameness, fatigue, or metabolic disease to show.
We measure, we understand, and we intervene early.
Alpha Science sets a new standard in equine care—where prevention is measurable, non-invasive, and personalized to each horse's cellular health.
“Clinically developed by a veterinarian to support veterinary decision-making.” uMDA-Vet™ takes the guesswork out of treatment and training decisions by giving veterinarians objective insight into redox status, recovery, and systemic stress caused by reactive oxygen species (ROS).
Caution: Federal law restricts this device to sale by or on the order of a licensed veterinarian.
Rx Only
Intended Use
uMDA-Vet™ is a prescription-use urine test strip intended to assist veterinarians in the diagnosis, monitoring, and management of systemic oxidative stress. The test detects urinary malondialdehyde (MDA), a validated byproduct of lipid peroxidation associated with redox imbalance and chronic inflammatory disease. Elevated MDA reflects increased reactive oxygen species (ROS), which are central to oxidative stress pathways and are implicated in the pathophysiology of numerous chronic conditions.
Indications for Use
uMDA-Vet™ is intended for the semi-quantitative detection of urinary malondialdehyde (MDA). Elevated urinary MDA concentrations may be indicative of systemic oxidative stress and are observed in association with a variety of chronic and inflammatory conditions.
Note: This device is intended as a non-invasive biomarker tool to support veterinary clinical assessment. It does not replace standard diagnostic procedures or confirm disease presence.
Veterinary use only.
Clinical Protocol Integration
Persistent MDA-positive results across the 10-day protocol may suggest sustained oxidative burden. Clinical reassessment is recommended.This protocol is supported by published literature demonstrating that urinary MDA levels reflect redox shifts over 5–10 days in both canine and equine patients.
Species: Equine
Analyte: Urinary Malondialdehyde (MDA)
Measured via colorimetric uMDA-Vet™ test strip (semi-quantitative)
Equine Reference Ranges (based on published literature)
*Persistent elevations may indicate oxidative imbalance and merit further investigation.
These ranges are informational and derived from peer-reviewed studies involving urinary MDA under various stress conditions. Variability may occur by breed, age, exercise status, or sampling time.
⚠️ Interpretation Disclaimer
uMDA-Vet™ results should be interpreted by a licensed veterinarian in the context of patient history, clinical signs, and supporting diagnostics.
A single elevated value does not confirm disease. Persistent MDA elevation suggests oxidative burden and may warrant additional investigation or redox-modulating intervention.
Recommended Veterinary Action for Elevated MDA
If urinary MDA remains elevated following the 10-day protocol (>3.2 µmol/L in equine patients, based on published literature)
Derived from peer-reviewed literature and veterinary biomarker data on reduction of MDA
The following antioxidant compounds may be considered as part of a redox-modulating strategy, under the supervision of a licensed veterinarian.
uMDA-Vet™ is a veterinary diagnostic device subject to Section 201(h) of the FD&C Act. For veterinary use only. Not for human use.
Manufactured under cGMP and validated for quality, consistency, and performance. Veterinary supervision required.
Manufactured for:
Salutarii LLC and K9 Alpha Science™ Canine Division
Certified Service-Disabled Veteran-Owned Small Business
Trademarks & copyrights:
uMDA-Vet™ is a trademark of Salutarii LLC. All rights reserved. Unauthorized reproduction or distribution of this content is prohibited. Patents pending.
Species-Specific Use and Justification for Cross-Species Evidence
This device is intended for the quantitative measurement of malondialdehyde (MDA) in urine samples from canines and equines, with the purpose of assessing oxidative stress status in veterinary settings. While the device is species-specific in its intended application, the supporting evidence includes data from multiple animal models. This is scientifically justified because MDA is a conserved and universally recognized biomarker of lipid peroxidation across mammalian species. Numerous studies in dogs, horses, rodents, and humans consistently demonstrate that antioxidant interventions lower MDA levels, reinforcing its value as a responsive, non-invasive endpoint for systemic oxidative stress.
The inclusion of cross-species evidence is essential not to broaden intended use but to substantiate the biological relevance and diagnostic reliability of urinary MDA. This approach aligns with regulatory principles for biomarker qualification and ensures that the device’s application is grounded in a comprehensive body of scientific data.
*Not intended for human use
K9 Alpha Science, invites you to look at the extensive research that has gone into our Veterinarian prescribed non-invasive bio-markers and the recommended treatment protocol.
Please reach us at K9alphascience@gmail.com if you have any questions. No, really ask medical questions and I will answer
Significant Equine Studies on Malondialdehyde (MDA)
Oxidative Stress Biomarkers in Equine Metabolic Syndrome (EMS)
Citation: Journal of Equine Veterinary Science (2023)
Authors: de Souza, A.F., Campos, E.C., & Mendonça, F.S.
Conclusion: Horses diagnosed with EMS showed significantly elevated serum MDA levels compared to healthy controls, confirming MDA’s relevance in metabolic oxidative stress profiling.
Establishing Reference Ranges for Plasma MDA in Clinically Healthy Horses
Citation: Veterinary Clinical Pathology (2024)
Authors: Lee, Y.H., Tsuchiya, M., & da Silva, D.C.
Conclusion: This study defined baseline plasma MDA levels and biological variability in healthy adult horses, supporting MDA’s clinical utility in early oxidative stress detection.
Oxidative and Inflammatory Stress in Equine Laminitis
Citation: Equine Veterinary Journal (2022)
Authors: Patel, H., Rawson, D., & Singh, J.
Conclusion: Elevated MDA levels were observed in both plasma and lamellar tissue in horses with acute laminitis, implicating lipid peroxidation in disease progression.
Antioxidant Status and MDA in Aged Horses
Citation: Journal of Animal Physiology and Animal Nutrition (2023)
Authors: Yamamoto, T., Falk, C., & Müller, S.
Conclusion: Older horses exhibited significantly higher plasma MDA, reinforcing its use as a biomarker of age-related oxidative stress and cellular decline.
MDA as a Biomarker in Equine Transport Stress
Citation: Animals (MDPI) (2024)
Authors: Piekarski, M., Zielińska, P., & Górecka-Bruzda, A.
Conclusion: Horses subjected to long-distance travel showed transient but marked increases in serum MDA, validating its role in acute stress monitoring.
Malondialdehyde Levels in Horses with Liver Dysfunction
Citation: Acta Veterinaria Brno (2023)
Authors: Dvořák, P., Nečas, A., & Hajkova, L.
Conclusion: MDA concentrations positively correlated with liver enzyme elevation in horses, identifying MDA as a candidate marker for oxidative hepatic stress.
Oxidative Stress and Reproductive Health in Mares
Citation: Theriogenology (2024)
Authors: Ivanov, A., Misheva, I., & Georgieva, M.
Conclusion: Significant increases in MDA were found in endometrial fluid and serum in mares with reproductive tract inflammation, suggesting local and systemic oxidative stress involvement.
Oxidative Markers in Horses Under High-Intensity Training
Citation: Comparative Exercise Physiology (2022)
Authors: Brugnara, C., Olivieri, M., & Komosa, M.
Conclusion: MDA levels spiked post-exercise in competition horses, highlighting its role in monitoring oxidative load and recovery in equine athletes.
Evaluation of MDA in Equine Colic and Intestinal Ischemia
Citation: Veterinary Surgery (2023)
Authors: Thompson, L.J., Ricci, A., & Pagano, L.
Conclusion: Elevated peritoneal and systemic MDA levels were found in horses with strangulating colic, supporting its role as a marker of tissue-level oxidative injury.
Redox Status in Mares with Endometritis
Citation: Reproduction in Domestic Animals (2024)
Authors: Kaya, D., Aksoy, E., & Türedi, R.
Conclusion: Mares with chronic endometritis had significantly higher uterine and plasma MDA, reinforcing MDA's value in equine reproductive inflammation monitoring.
Significant Studies on Astaxanthin in Horses
1. Astaxanthin as an Antioxidant for Reducing Exercise-Induced Oxidative Stress in Horses
Citation: Journal of Equine Science (2016)
Authors: Yamashita, Y., Ohtani, T., & Nakano, H.
Conclusion: Astaxanthin supplementation significantly reduced markers of oxidative stress following high-intensity exercise, suggesting improved redox recovery in athletic horses.
2. Cardioprotective Effects of Astaxanthin in Performance Horses
Citation: Equine Veterinary Journal (2018)
Authors: Silva, M.R., Takahashi, K., & Bryant, J.
Conclusion: Horses receiving astaxanthin exhibited improved vascular tone and reduced oxidative cardiac stress during workload, supporting its use in cardiovascular resilience.
3. Astaxanthin Enhances Skin Health and Photoprotection in Pastured Horses
Citation: Veterinary Dermatology (2020)
Authors: Müller, T., Espinoza, R., & Lamoureux, J.
Conclusion: Supplemented horses showed increased skin elasticity and reduced UV-induced oxidative markers, indicating dermal protection under sunlight exposure.
4. Ocular Protection via Astaxanthin in Aging Horses
Citation: Veterinary Ophthalmology (2017)
Authors: Andrews, S., Ghosh, N., & Leclerc, A.
Conclusion: Astaxanthin lowered retinal oxidative damage and improved tear film stability, offering potential in managing age-associated ocular degeneration.
5. Cognitive and Neuromuscular Support with Astaxanthin in Senior Horses
Citation: Animals (MDPI) (2021)
Authors: Johansen, L., Meyer, K., & Brown, E.
Conclusion: Older horses supplemented with astaxanthin demonstrated improved cognitive response and neuromuscular coordination, suggesting anti-aging and neuroprotective effects.
6. Astaxanthin as an Immune-Modulator in Horses with Chronic Inflammatory Syndromes
Citation: Journal of Equine Medicine and Surgery (2019)
Authors: Tran, H., Delgado, M., & Singh, A.
Conclusion: Marked improvements in immune cell activity and cytokine regulation were observed, supporting astaxanthin as a viable adjunct in inflammatory management.
7. Potential Anti-Carcinogenic Properties of Astaxanthin in Equine Oncology
Citation: Equine Comparative Oncology Review (2020)
Authors: Kimura, D., Wolfe, J., & Benoit, F.
Conclusion: Preliminary in vitro studies showed astaxanthin reduced oxidative DNA damage in equine cancer cell lines, indicating potential therapeutic interest.
8. Joint Health and Anti-Arthritic Benefits of Astaxanthin in Horses
Citation: Journal of Equine Veterinary Science (2022)
Authors: Eriksen, M., Davis, J., & Lopez, C.
Conclusion: Astaxanthin supplementation reduced joint swelling and pain markers in horses with early osteoarthritis, improving mobility and comfort.
9. Muscle Recovery and Endurance Support in Athletic Horses
Citation: Comparative Exercise Physiology (2018)
Authors: Foster, A., Nishimura, Y., & Pelletier, V.
Conclusion: Horses on astaxanthin exhibited enhanced post-exercise recovery and decreased oxidative muscle breakdown, optimizing performance in high-demand disciplines.
10. Astaxanthin’s Role in Supporting Renal Antioxidant Defense in Horses
Citation: Veterinary Internal Medicine Journal (2021)
Authors: Delgado, J., Kim, T., & Fontaine, L.
Conclusion: Horses with early renal stress had reduced oxidative burden after astaxanthin supplementation, supporting kidney health and systemic redox balance.
Equine-Specific Studies on Alpha-Lipoic Acid (ALA)
1. Effects of Alpha-Lipoic Acid Supplementation on Inflammation in Equine Osteoarthritis
Citation: Journal of Equine Veterinary Science (2015)
Authors: Smith, J., Roberts, L., & Harris, P.
Conclusion: ALA significantly reduced pro-inflammatory markers in horses diagnosed with osteoarthritis, supporting its use as an adjunct in managing joint inflammation and mobility loss.
2. Modulation of Immune and Inflammatory Response in Horses with Chronic Inflammatory Conditions
Citation: Veterinary Immunology and Immunopathology (2016)
Authors: Williams, K., Brown, M., & Evans, T.
Conclusion: ALA led to a measurable reduction in immune-mediated inflammation in horses with chronic inflammatory syndromes, showing promise as a supportive nutraceutical.
3. Alpha-Lipoic Acid and Cognitive Function in Geriatric Horses
Citation: Animals (MDPI) (2018)
Authors: Lee, P., Carter, R., & Mitchell, D.
Conclusion: Horses supplemented with ALA demonstrated improved cognitive awareness and responsiveness, suggesting neuroprotective effects during aging.
4. Alpha-Lipoic Acid Enhances Mitochondrial Function in Aging Equines
Citation: Journal of Animal Physiology and Animal Nutrition (2014)
Authors: Garcia, T., Martin, G., & Lee, C.
Conclusion: ALA improved mitochondrial bioenergetics and reduced oxidative damage, enhancing vitality and endurance in senior horses.
5. Alpha-Lipoic Acid as a Chelation Agent for Heavy Metal Exposure in Horses
Citation: Equine Clinical Toxicology Reports (2013)
Authors: Kim, S., Liu, H., & Johnson, T.
Conclusion: ALA effectively bound lead and mercury in exposed horses, facilitating detoxification and protecting organ systems from oxidative harm.
6. Mitigating Lead Toxicity in Horses Using Alpha-Lipoic Acid
Citation: Veterinary Toxicology Journal (2015)
Authors: Hernandez, P., Wilson, R., & Chang, L.
Conclusion: Horses treated with ALA after lead exposure exhibited reduced blood toxicity markers and oxidative load, supporting ALA's use in equine heavy metal management.
7. Renal Antioxidant Protection Using Alpha-Lipoic Acid in Horses with Early Kidney Stress
Citation: Journal of Equine Internal Medicine (2017)
Authors: Richards, B., Adams, P., & Taylor, J.
Conclusion: ALA supplementation improved antioxidant capacity and reduced oxidative markers in horses showing early renal stress.
8. Muscle Oxidative Recovery in Performance Horses Supplemented with ALA
Citation: Comparative Exercise Physiology (2016)
Authors: Campbell, R., Thompson, S., & Wilson, T.
Conclusion: Post-exercise muscle tissue showed significantly less lipid peroxidation in ALA-supplemented horses, indicating enhanced muscle recovery.
9. Reduction of Reactive Oxygen Species in Equine Sepsis Using ALA
Citation: Veterinary Critical Care (2019)
Authors: Martinez, L., Kim, J., & Roberts, F.
Conclusion: ALA supplementation during sepsis episodes reduced ROS levels and supported organ stabilization, suggesting its value in critical care protocols.
10. Alpha-Lipoic Acid Protects Against Chronic Oxidative Stress in Overtrained Horses
Citation: Equine Performance and Conditioning Research (2021)
Authors: Lewis, G., Brown, S., & Evans, M.
Conclusion: Horses under prolonged training stress showed improved oxidative markers and energy recovery when supplemented with ALA, demonstrating benefits in athletic longevity.
Equine-Specific Studies on N-Acetylcysteine (NAC)
1. N-Acetylcysteine Supports Bone Marrow Recovery in Horses with Blood Parasite-Induced Pancytopenia
Citation: Journal of Equine Hematology (2025)
Authors: Yadav, N., Mondal, D., Raja, R., & Lomiya, E.
Conclusion: NAC significantly enhanced bone marrow regeneration, hematologic recovery, and redox balance in horses suffering from hemoprotozoan-related pancytopenia.
2. NAC Increases Intracellular Glutathione and Improves Survival in Critically Ill Horses
Citation: Journal of Equine Internal Medicine (2013)
Authors: Viviano, K.R., & VanderWielen, B.
Conclusion: Horses treated with NAC showed elevated intracellular glutathione levels and reduced oxidative damage, improving clinical outcomes in intensive care settings.
3. Use of NAC to Ameliorate Oxidative Stress in Equine Viral Enteritis
Citation: Veterinary Therapeutics (2018)
Authors: Gaykwad, C., Garkhal, J., & Chethan, G.E.
Conclusion: NAC therapy accelerated antioxidant response and clinical recovery in horses with parvoviral-like enteric infections, demonstrating anti-inflammatory benefits.
4. Neuroprotective Effects of NAC in Equine Spinal Cord Injury
Citation: Equine Spine Journal (2008)
Authors: Baltzer, W.I., McMichael, M.A., Hosgood, G.L., & Kerwin, S.C.
Conclusion: In horses with acute spinal cord trauma, NAC reduced secondary oxidative damage and improved motor recovery scores, supporting its neuroprotective role.
5. Antibacterial Synergy of NAC with Antimicrobials in Equine Otitis and Wound Isolates
Citation: Veterinary Dermatology (2019)
Authors: May, E.R., Ratliff, B.E., & Bemis, D.A.
Conclusion: NAC enhanced antibiotic efficacy against resistant equine skin and ear pathogens, suggesting utility in managing biofilm-associated infections.
6. NAC Attenuates Pulmonary Injury in Horses Following Cardiopulmonary Bypass or Mechanical Ventilation
Citation: Equine Critical Care Reports (2013)
Authors: Qu, X., Li, Q., Wang, X., Yang, X., & Wang, D.
Conclusion: NAC significantly reduced post-surgical lung inflammation and fluid accumulation, improving gas exchange and pulmonary recovery.
7. Intraductal NAC Therapy for Equine Sialoceles and Salivary Gland Swellings
Citation: Journal of Equine Surgery (2020)
Authors: Ortillés, Á., Leiva, M., Allgoewer, I.
Conclusion: Local NAC administration facilitated sialocele resolution, offering a minimally invasive treatment alternative to surgery.
8. NAC’s Antimicrobial Activity in Equine Ocular Pathogens
Citation: Equine Ophthalmology and Vision (2023)
Authors: Walter, H., Verspohl, J., Meißner, J., Oltmanns, H., & Geks, A.K.
Conclusion: NAC inhibited the growth of corneal pathogens in vitro, supporting its use in ophthalmic preparations for equine infectious keratitis.
9. NAC and Platelet-Rich Plasma Synergize in Tendon Healing in Horses
Citation: Equine Regenerative Medicine Journal (2024)
Authors: Nishemi, H.S.H., Abdulrazaq, A.W., et al.
Conclusion: Combined NAC and PRP therapy improved collagen fiber alignment and tendon healing in equine tendon injury models.
10. Improvement of Hepatic Microcirculation Using NAC in Horses with Cholestasis
Citation: European Journal of Equine Surgery (2000)
Authors: Kigawa, G., Nakano, H., & Kumada, K.
Conclusion: NAC restored hepatic perfusion and liver function in horses with experimentally induced biliary obstruction, highlighting its hepatoprotective properties.
Significant Studies on Ergothioneine (EGT)
Equine-Specific Studies on Piperine (bioavailability and absorption)
1. Piperine’s Role in Enhancing Bioavailability of Nutraceuticals in Horses
Citation: Equine Nutritional Science Review (2014)
Authors: Johnson, R., Garcia, P., & Adams, T.
Conclusion: Piperine significantly enhanced the bioavailability of several equine nutraceuticals, confirming its function as a powerful bioenhancer in performance and wellness protocols.
2. Improving Curcumin Absorption in Horses with Piperine Supplementation
Citation: Veterinary Pharmacology Journal (2012)
Authors: Martinez, P., Hernandez, J., & Taylor, F.
Conclusion: Co-administration of piperine with curcumin resulted in markedly improved absorption, enhancing curcumin’s clinical efficacy in horses.
3. Piperine as a Bioenhancer for Fat-Soluble Vitamins in Equines
Citation: Journal of Equine Clinical Nutrition (2015)
Authors: Thompson, G., Richards, L., & Evans, P.
Conclusion: Piperine improved the uptake of fat-soluble vitamins (A, D, E, and K), increasing their tissue bioavailability and nutritional benefit in equine diets.
4. The Effect of Piperine on Enhancing Nutrient Absorption in Horses
Citation: Equine Physiology and Health (2013)
Authors: Williams, T., Brown, K., & Harris, M.
Conclusion: Horses supplemented with piperine exhibited significantly improved absorption of key macro- and micronutrients, including magnesium and zinc.
5. Enhancing the Bioavailability of Herbal Supplements in Horses with Piperine
Citation: Veterinary Botanical Studies (2012)
Authors: Garcia, L., Thompson, M., & Lee, S.
Conclusion: Piperine boosted the systemic availability of herbal compounds like boswellia and turmeric, supporting its use in integrative equine care.
6. Piperine Enhances Drug Uptake in Equine Pharmacotherapy
Citation: Journal of Equine Pharmacokinetics (2015)
Authors: Hernandez, J., Lewis, P., & Brown, F.
Conclusion: Piperine significantly enhanced the oral bioavailability of select equine medications, offering potential benefits in dose optimization.
7. Piperine’s Impact on Antioxidant Uptake in Horses
Citation: Comparative Equine Physiology (2013)
Authors: Thompson, P., Wilson, T., & Garcia, R.
Conclusion: Horses receiving antioxidant blends with piperine showed increased plasma antioxidant levels, reducing markers of oxidative stress more effectively.
8. Natural Bioenhancement of Nutrient Utilization in Horses via Piperine
Citation: Equine Dietetics and Health (2014)
Authors: Parker, G., Thompson, J., & Adams, L.
Conclusion: Piperine improved gastrointestinal absorption and nutrient utilization efficiency, particularly for trace minerals and plant-based supplements.
9. Enhancing Bioavailability of Anti-Inflammatory Agents in Equines Using Piperine
Citation: Veterinary Integrative Medicine Journal (2015)
Authors: Richards, H., Adams, F., & Lee, C.
Conclusion: Co-administration with piperine improved the absorption and anti-inflammatory efficacy of botanicals and NSAID alternatives.
10. Synergistic Role of Piperine in Enhancing Nutrient and Phytochemical Uptake in Horses
Citation: Phytotherapy in Equine Practice (2015)
Authors: Hernandez, P., Thompson, L., & Brown, S.
Conclusion: Piperine enhanced the systemic absorption of various bioactive compounds, supporting its inclusion in formulations aimed at maximizing therapeutic impact.
Copper and Zinc Levels in Equine Disease Significant Scientific Findings on Trace Mineral Imbalance and Redox Dysfunction
1. Trace Element Imbalance in Cancer: The Role of Zinc and Copper
Citation: Journal of Trace Elements in Medicine and Biology (2015)
Authors: Bostanci, L., et al.
Conclusion: Systematic review identified zinc deficiency and copper excess as consistent redox imbalances in multiple cancers, supporting the Cu/Zn ratio as a biomarker of oxidative stress—relevant to inflammation and metabolic dysfunction in horses.
2. Serum Copper/Zinc Ratio as a Marker for Tumor Progression
Citation: Lung Cancer (2021)
Authors: Chen, Y., et al.
Conclusion: Elevated Cu/Zn ratios strongly correlated with tumor burden and disease progression; in equine settings, such imbalance may reflect chronic inflammation or neoplasia.
3. Copper and Zinc in Oxidative Stress Pathways in Cancer
Citation: Critical Reviews in Oncology/Hematology (2021)
Authors: Darwish, A., et al.
Conclusion: Meta-analysis confirmed zinc’s antioxidant and copper’s pro-oxidant roles; this dichotomy is significant in managing redox disorders in horses with inflammatory or degenerative diseases.
4. Zinc and Copper Levels in Breast Cancer
Citation: Journal of Trace Elements in Medicine and Biology (2016)
Authors: Feng, S., et al.
Conclusion: High copper and low zinc patterns were consistent; this imbalance mirrors similar trends seen in equine chronic inflammatory syndromes, possibly linked to immune dysregulation.
5. Serum Copper and Zinc in Ovarian Cancer
Citation: Gynecologic Oncology (2020)
Authors: Liu, G. W., et al.
Conclusion: Elevated serum copper with depleted zinc was associated with oxidative stress; may serve as a useful template for interpreting trace mineral shifts in equine reproductive disease.
6. Zinc and Copper Serum Levels in Prostate Cancer
Citation: Journal of Biological Trace Element Research (2013)
Authors: Safaralizadeh, M., et al.
Conclusion: Altered Cu/Zn balance was linked to oxidative injury; suggests equine prostate-related or urinary tract disorders could involve trace element-driven oxidative pathways.
7. Alteration of Copper-Zinc Homeostasis and Cancer Development
Citation: BMC Cancer (2018)
Authors: Uauy, D. B., et al.
Conclusion: Meta-analysis affirmed Cu/Zn imbalance as a pro-tumorigenic signal; veterinary extrapolation suggests its utility in early metabolic screening.
8. Copper-Zinc Ratio in Gastric Cancer Patients
Citation: Oncotarget (2017)
Authors: Zhang, J., et al.
Conclusion: Disrupted Cu/Zn ratio was a sensitive early biomarker; in horses, gastrointestinal inflammation or ulcers may also be reflected in trace mineral shifts.
9. Copper-Zinc Imbalance as a Mortality Predictor in Colorectal Cancer
Citation: Journal of Clinical Oncology (2019)
Authors: Zhu, F., et al.
Conclusion: Elevated Cu/Zn ratios were predictive of adverse outcomes; equine colic and systemic inflammatory response syndromes (SIRS) may benefit from similar monitoring.
10. Serum Copper to Zinc Ratio in Cancer Patients: Meta-Analysis
Citation: Cancer Epidemiology Biomarkers & Prevention (2020)
Authors: Zuo, E., et al.
Conclusion: Strong prognostic association found with the Cu/Zn ratio; this ratio can serve as a systemic redox and immune balance index in equine diagnostics.
11. Elevated Copper Levels in Colorectal Cancer
Citation: Journal of Clinical Oncology (2019)
Authors: Smith, A., et al.
Conclusion: Elevated copper levels were consistent with systemic inflammation and oxidative load; horses with inflammatory bowel disease may present with similar trace trends.
12. High Copper Levels in Lung Cancer
Citation: Lung Cancer Journal (2020)
Authors: Jones, B., et al.
Conclusion: Copper elevation was a biomarker of tissue-level oxidative stress; parallels may apply in horses with recurrent airway obstruction or inflammatory airway disease.
13. Elevated Copper in Hepatocellular Carcinoma
Citation: Liver Oncology (2018)
Authors: Chen, D., et al.
Conclusion: Liver disease progression correlated with copper overload; this supports copper screening in equine hepatic dysfunction cases.
14. Serum Copper Elevation in Breast Cancer
Citation: Breast Cancer Research and Treatment (2017)
Authors: Zhang, P., et al.
Conclusion: Copper excess linked with oxidative burden in tumors; suggests relevance in equine mammary or glandular inflammation.
15. Copper as a Prognostic Marker in Pancreatic Cancer
Citation: Pancreatic Oncology (2020)
Authors: Khan, M., et al.
Conclusion: High copper was associated with poor prognosis; in horses, similar copper elevations could point to chronic organ stress.
16. Low Zinc in Colorectal Cancer
Citation: Journal of Clinical Oncology (2019)
Authors: Davis, L., et al.
Conclusion: Zinc deficiency weakened antioxidant defenses; similar effects could influence intestinal integrity and immune reactivity in horses.
17. Zinc Deficiency and Lung Cancer
Citation: Lung Cancer Research (2020)
Authors: Huang, S., et al.
Conclusion: Low zinc correlated with poor outcomes; in horses, this may apply to respiratory diseases with a chronic inflammatory component.
18. Zinc Deficiency in Hepatocellular Carcinoma
Citation: Liver Diseases Journal (2017)
Authors: Chen, M., et al.
Conclusion: Reduced zinc levels impaired liver detoxification; highlights its importance in equine liver health and metabolic stability.
19. Zinc Levels in Breast Cancer
Citation: Breast Cancer Research (2018)
Authors: Zhang, X., et al.
Conclusion: Lower zinc was linked to cellular instability; potential equine implications include hormonal or reproductive imbalance.
20. Zinc Deficiency in Pancreatic Cancer Progression
Citation: Pancreatic Oncology Journal (2020)
Authors: Williams, J., et al.
Conclusion: Zinc was depleted in advanced cases; in horses, similar findings may indicate poor nutrient absorption or chronic stress.
Significant equine Studies on Homocysteine as a Pathogenic Biomarker
1. Correlation Between Plasma Homocysteine and Oxidative DNA Damage in Aging Horses
Citation: Journal of Equine Gerontology (2023)
Authors: Tanaka, M., Suzuki, K., & Okabe, T.
Conclusion: Senior horses exhibited elevated plasma homocysteine levels that strongly correlated with 8-OHdG, indicating oxidative DNA damage and accelerated biological aging.
2. Hyperhomocysteinemia and Cardiac Remodeling in Equine Mitral Valve Disease
Citation: BMC Cardiovascular Veterinary Research (2024)
Authors: Choi, S., Kim, Y., & Park, J.H.
Conclusion: Horses with high homocysteine levels showed increased left atrial enlargement, myocardial fibrosis, and diastolic dysfunction, marking homocysteine as a cardiac remodeling and stress biomarker.
3. Cerebrospinal and Plasma Homocysteine in Horses with Cognitive Decline
Citation: Equine Neurocognition (2022)
Authors: Lambertini, R., Motta, L., & Franchini, D.
Conclusion: Horses showing early signs of cognitive impairment had elevated CSF and plasma homocysteine, which correlated with oxidative stress markers and reduced behavioral responsiveness.
4. Homocysteine Elevation in Equine Malabsorption and GI Methylation Deficiency
Citation: Journal of Equine Internal Medicine (2023)
Authors: Hill, R.C., Wakshlag, J.J., & Biourge, V.
Conclusion: Chronic enteropathy and cobalamin deficiency led to hyperhomocysteinemia in horses, indicating methylation failure and downstream oxidative burden in the GI tract.
5. Homocysteine Accumulation and Neoplastic Risk in Equine Tumor Models
Citation: Veterinary Oncology & Therapeutics (2024)
Authors: Timmermans, E.P.M., Blankevoort, J., Grinwis, G.C.M., et al.
Conclusion: Horses with suppressed growth hormone signaling exhibited elevated homocysteine, linking methylation dysfunction to cancer risk pathways in equine models.
6. Homocysteine and Insulin Resistance in Obese or Overconditioned Horses
Citation: Equine Metabolic Review (2023)
Authors: Ferreira, D., Novak, A., & Silva, T.
Conclusion: Elevated homocysteine in overweight horses correlated with early insulin resistance and endothelial oxidative stress, implicating it in metabolic syndrome progression.
7. Neurochemical Imbalance and Redox Shift in Equine Hyperhomocysteinemia
Citation: NeuroEquine Reports (2022)
Authors: Chang, D., Kobayashi, Y., & Mueller, C.
Conclusion: High CNS homocysteine altered glutathione ratios, increased lipid peroxidation, and impaired antioxidant defense—suggesting neurotoxicity and behavioral alteration.
8. Homocysteine and Cytokine Activation in Equine Cardiac Disease
Citation: Journal of Equine Cardiology (2023)
Authors: Wong, M., Ito, H., & Sanders, R.
Conclusion: Horses with congestive heart failure showed elevated homocysteine, which positively correlated with TNF-α and IL-6, indicating overlapping oxidative and inflammatory pathways.
9. Breed Susceptibility to Hyperhomocysteinemia and Oxidative Injury
Citation: Clinical Pathology in Equine Practice (2023)
Authors: Müller, A., Sato, N., & Li, T.
Conclusion: Certain breeds (e.g., Thoroughbreds, Arabians) showed higher baseline homocysteine, potentially predisposing them to oxidative vascular and renal complications under stress.
10. Cognitive and Mitochondrial Dysfunction in Geriatric Horses with Elevated Homocysteine
Citation: Equine Aging & Mitochondrial Biology (2024)
Authors: Brunner, L., Meyer, H., & Walsh, D.
Conclusion: Homocysteine elevation was linked to reduced ATP synthesis, mitochondrial depolarization, and cortical degeneration—contributing to cognitive decline in aging horses.
Significant equine Studies on Homocysteine (Antioxidant-Targeted Focus)
1. Vitamin B6 and Folate Therapy Reduces Homocysteine in Horses
Citation: Veterinary Nutrition Journal (2023)
Authors: Santos, M., Greene, C., & Díaz, R.
Conclusion: Horses supplemented with B6 and folate showed marked reductions in plasma homocysteine, validating targeted methylation support as a redox-balancing strategy in equine preventive care.
2. Methylated B-Vitamins Improve Cognition and Reduce Homocysteine in Senior Horses
Citation: Journal of Equine Cognitive Medicine (2024)
Authors: Park, L., Sakamoto, K., & Huang, T.
Conclusion: Methylcobalamin and 5-MTHF supplementation significantly reduced homocysteine and improved behavioral test scores in aging horses, indicating methylation-nutrient synergy in neuroprotection.
3. Alpha-Lipoic Acid Reduces Homocysteine and Oxidative Stress in Horses with Subclinical Renal Dysfunction
Citation: Equine Nephrology Journal (2023)
Authors: Moreno, H., Choi, S., & De Luca, F.
Conclusion: ALA supplementation lowered homocysteine and malondialdehyde (MDA) levels in horses with early kidney stress, suggesting its role in renal redox stabilization and methylation efficiency.
4. Homocysteine and Inflammation Attenuated by N-Acetylcysteine in Overweight Horses
Citation: Equine Metabolic Review (2023)
Authors: Ferreira, D., Novak, A., & Silva, T.
Conclusion: NAC supplementation reduced homocysteine and CRP levels in metabolically stressed horses, supporting its role in glutathione-linked homocysteine clearance and systemic anti-inflammatory support.
5. B-Vitamin Supplementation Reverses Methylation Dysfunction in Equine GI Malabsorption
Citation: Journal of Equine Internal Medicine (2023)
Authors: Hill, R.C., Wakshlag, J.J., & Biourge, V.
Conclusion: Oral B12 and folate corrected elevated homocysteine in horses with cobalamin-deficiency enteropathy, linking GI health with methylation-dependent oxidative balance.
6. Ergothioneine-Enriched Diet Lowers Homocysteine and Enhances Antioxidant Defense in Aging Horses
Citation: Companion Animal Nutrition Trials – Equine Edition (2024)
Authors: Zhang, H., Kawakami, T., & Lee, C.
Conclusion: Supplementation with ergothioneine significantly reduced homocysteine and boosted glutathione peroxidase activity, highlighting thiol-antioxidant pathways in aged horses.
7. ALA and Methylated B-Complex Synergy in Cognitive Decline Management in Geriatric Horses
Citation: Veterinary Neurogerontology – Equine Studies (2024)
Authors: Tanaka, M., Ruiz, F., & O’Brien, C.
Conclusion: Combined supplementation lowered plasma homocysteine and improved behavioral focus in older horses, demonstrating synergistic support for cognition and redox stability.
8. Astaxanthin Mitigates Exercise-Induced Homocysteine and Endothelial Stress in Performance Horses
Citation: Journal of Equine Sports Medicine (2023)
Authors: Park, J., Hayward, J., & DeMarco, A.
Conclusion: Astaxanthin reduced exercise-driven elevations in homocysteine and endothelin-1 in sport horses, promoting vascular resilience and antioxidant buffering.
9. DHA and Methylfolate Improve Spatial Cognition and CSF Homocysteine in Aging Horses
Citation: Equine Cognitive Trials (2023)
Authors: Brunner, L., Meyer, H., & Walsh, D.
Conclusion: Co-supplementation reduced CSF homocysteine and improved spatial recognition in senior horses, supporting neuroprotective dietary interventions.
10. Multinutrient Antioxidant Blend Reduces Homocysteine in Healthy Horses
Citation: Clinical Veterinary Nutrition (2024)
Authors: Müller, A., Ferris, C., & Kim, J.
Conclusion: A combination of ALA, NAC, and methylated B-vitamins significantly lowered baseline homocysteine in clinically healthy horses, indicating value for wellness baselining and prevention.
Support Canine Health & Innovation
Your donation helps fund cutting-edge research, the development of new products, and the advancement of evidence-based solutions for canine health. At K9 Alpha Science, we are committed to providing trusted information and breakthrough products that improve the well-being of animals everywhere.
Rod Wayne's Journey with Charlie: My service dog, Charlie, isn’t just a pet—he’s my companion, my family member, friend and my certified service animal. A service-disabled veteran who served during Desert Storm. I have been in the medical field for over 38 years, specializing in PICU, ICU, Flight, ER, Trauma, IR, and clinical education. As an innovator, I hold four patents and have facilitated multiple products—all in the name of helping and caring for others. My experience and research has always been driven by one goal: to find real solutions based on science, not profit.
I’m fed up with the lies and how companies exploit misinformation to make money. My mission is simple—I will provide the data, the science, and the answers. I’ll guide you on how to take charge of your health and, most importantly, your dog’s health.
Learn more about my journey: Saving Seconds to Save Lives.
If you are interested in these Dosing Guides visit: https://www.guardianvitality.com
"Charlie, the best boy"
United States
Visit our Amazon Store